For most fertility physicians in China, in addition to the experience from their own clinical practice, they largely rely on the woman's age, the presence or absence of polycystic ovary (PCO) appearance, and the basal FSH levels to determine the starting dose of gonadotrophins for stimulation. This evidence concerns the gene BRD2 and polycystic ovary syndrome.